A New Tool to Promote Patient's Engagement in Their Healthcare Process
Launched by EUROPEAN INSTITUTE OF ONCOLOGY · Dec 31, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping women who have been diagnosed with early-stage breast cancer make important decisions about their treatment options. The goal is to create a new tool that can guide patients in understanding their choices and selecting the best treatment for their specific situation. This study will test how effective this tool is in assisting patients during their decision-making process.
To be eligible for the trial, participants must be at least 18 years old and have been diagnosed with early-stage breast cancer that can be surgically removed. They should also be preparing to start treatment for their cancer and be able to provide consent to participate. Women with certain psychological or cognitive issues, advanced cancer, or other serious health conditions may not be able to join. Although the trial is not yet recruiting participants, those who take part can expect to receive support in understanding their treatment options, which can help them feel more engaged and confident in their healthcare journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • be 18 or older;
- • have received/receive diagnosis of resectable breast cancer in the early stage;
- • women treated or who will undergo oncological treatment for early breast cancer;
- • demonstrate the absence of psychopathological features.
- • be willing and able to provide written informed consent/assent for the trial
- Exclusion Criteria:
- • breast cancer patients who showed physical or psychological issues, as well as cognitive impairments that prohibited their participation in this type of study;
- • neurological or psychiatric disorders that may compromise the patients' ability to take part in the study.
- • Distant metastases from breast cancer or locally advanced/unresectable disease
- • Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
About European Institute Of Oncology
The European Institute of Oncology (IEO) is a leading research and treatment center based in Milan, Italy, dedicated to advancing cancer care through innovative clinical research and personalized medicine. Renowned for its commitment to multidisciplinary approaches, IEO integrates cutting-edge research with clinical practice to improve patient outcomes. The institute actively sponsors and conducts clinical trials across various cancer types, fostering collaboration between oncologists, researchers, and industry partners. With a focus on translating scientific discoveries into effective therapies, IEO plays a pivotal role in the global fight against cancer, contributing to the development of new treatment protocols and enhancing the understanding of oncological diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Trial Officials
Gabriella Pravettoni
Principal Investigator
European Institute of Oncology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported